|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.931
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.923
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.754
|
|
|
|
positive regulation of megakaryocyte differentiation
|
GO:0045654 |
4 |
0.699
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.623
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
18 |
0.599
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.576
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.547
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.531
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.395
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.389
|
|
|
|
regulation of megakaryocyte differentiation
|
GO:0045652 |
7 |
0.383
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.361
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.333
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.315
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.315
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
1 |
0.301
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.284
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.266
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.235
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.216
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.215
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.205
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.201
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.194
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.189
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.189
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.186
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.178
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.165
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.164
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.163
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.163
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.159
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.155
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.155
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.153
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.141
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.140
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.137
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.136
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.136
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.132
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.130
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.129
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.125
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.122
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.122
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.121
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.118
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.118
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.117
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.114
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.112
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.109
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.105
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.103
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.103
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.102
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.102
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.100
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.099
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.099
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.099
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.099
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.096
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.096
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.095
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.094
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.093
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.092
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.092
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.089
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.089
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.088
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.087
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.087
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.086
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.086
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.085
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.085
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.085
|
|
|
|
ammonium transmembrane transport
|
GO:0072488 |
2 |
0.084
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.083
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.082
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.081
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.081
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.080
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.080
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.079
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.078
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.077
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.077
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.076
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.075
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.075
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.074
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.073
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.071
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.071
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.071
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.070
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.070
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.068
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.068
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.067
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.066
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.065
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.065
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.065
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.065
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.064
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.062
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.061
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.061
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.061
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.061
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.061
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.061
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.060
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.060
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.060
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.060
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.060
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.060
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.059
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.059
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.059
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.059
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.059
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.059
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.058
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.058
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.057
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.057
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.057
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.057
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.057
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.057
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.056
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.056
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.055
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.055
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.055
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.054
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.054
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.053
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.053
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.053
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.052
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.052
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.052
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.052
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.052
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.052
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.051
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.051
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.051
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.051
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.050
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.050
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.050
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.050
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.050
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.049
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.049
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.048
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.048
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.048
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.048
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.048
|
|
|
|
primitive hemopoiesis
|
GO:0060215 |
7 |
0.048
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.047
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.046
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.046
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.046
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.045
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.045
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.045
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.045
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.045
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.045
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.044
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.044
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.044
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.044
|
|
|
|
regulation of cell proliferation involved in mesonephros development
|
GO:2000606 |
1 |
0.043
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.043
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.043
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.043
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.043
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.043
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.043
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.042
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.042
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.041
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.041
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.041
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.040
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.040
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.040
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.040
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.040
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.039
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.039
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.039
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.039
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.039
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.039
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.039
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.039
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.039
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.039
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.039
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.038
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.038
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.038
|
|
|
|
positive regulation of hematopoietic progenitor cell differentiation
|
GO:1901534 |
6 |
0.038
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.038
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.038
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.037
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.037
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.037
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.037
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.037
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.037
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.036
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.036
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.036
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.036
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.036
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.036
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.036
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.036
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.036
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.036
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.036
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.035
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.035
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.035
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.035
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.035
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.035
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.035
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.034
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.034
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.034
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.034
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.034
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.034
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.034
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.034
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.033
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.033
|
|
|
|
chemokine production
|
GO:0032602 |
34 |
0.033
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.033
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.033
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.033
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.033
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.032
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.032
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.032
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.032
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.031
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.031
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.031
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.031
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.031
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.031
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.030
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.030
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.030
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.030
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.030
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.030
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.030
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.030
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.030
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.030
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.030
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.029
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.029
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.029
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.029
|
|
|
|
gene looping
|
GO:0090202 |
2 |
0.029
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.029
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.029
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.029
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
22 |
0.029
|
|
|
|
defense response to nematode
|
GO:0002215 |
4 |
0.028
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.028
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.028
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.028
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.028
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.028
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.028
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.028
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.027
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.027
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.027
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.027
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.027
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.027
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.027
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.027
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.027
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.027
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.027
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.027
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.027
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.026
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.026
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.026
|
|
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
4 |
0.026
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.026
|
|
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
5 |
0.026
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.026
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.026
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.026
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.025
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.025
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.025
|
|
|
|
urea transport
|
GO:0015840 |
4 |
0.025
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.025
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.025
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.025
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.025
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.025
|
|
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.025
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.025
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.025
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.025
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.025
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.025
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.025
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.025
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.025
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.025
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.024
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.024
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.024
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.024
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.024
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.024
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.024
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.024
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.024
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.024
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.024
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.024
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.023
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.023
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.023
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.023
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.023
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.023
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.023
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.023
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.023
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
20 |
0.023
|
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.023
|
|
|
|
l alanine transport
|
GO:0015808 |
3 |
0.023
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.023
|
|
|
|
growth of symbiont in host
|
GO:0044117 |
23 |
0.023
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.022
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
regulation of definitive erythrocyte differentiation
|
GO:0010724 |
3 |
0.022
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.022
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.022
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
10 |
0.022
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.022
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.022
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.022
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.022
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.022
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.022
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.021
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.021
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.021
|
|
|
|
regulation of anion transport
|
GO:0044070 |
27 |
0.021
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.021
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.021
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.021
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.021
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.021
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.021
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.021
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.021
|
|
|
|
regulation of hormone metabolic process
|
GO:0032350 |
15 |
0.020
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.020
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.020
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.020
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.020
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.020
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.020
|
|
|
|
dsdna loop formation
|
GO:0090579 |
2 |
0.020
|
|
|
|
epidermal cell fate specification
|
GO:0009957 |
1 |
0.020
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.020
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.020
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.020
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.020
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.019
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.019
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.019
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.019
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.019
|
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
19 |
0.019
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.019
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.019
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.019
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.019
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.019
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.019
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.019
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.019
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.019
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.019
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.018
|
|
|
|
regulation of interleukin 4 production
|
GO:0032673 |
18 |
0.018
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.018
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.018
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.018
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.018
|
|
|
|
negative regulation of interleukin 8 production
|
GO:0032717 |
1 |
0.018
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.018
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.018
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.018
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.018
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.018
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
27 |
0.018
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.018
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.018
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.018
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.018
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.018
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.018
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.018
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.017
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.017
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.017
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.017
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.017
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.017
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.017
|
|